Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 206-996-5 | CAS number: 420-46-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Exposure related observations in humans: other data
Administrative data
- Endpoint:
- exposure-related observations in humans: other data
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2006
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Published peer reviewed results from high quality research organization
Data source
Reference
- Reference Type:
- publication
- Title:
- Experimental exposure to 1,1,1-trifluoroethane (HFC-143a): Uptake, disposition and acute effects in male volunteers
- Author:
- Gunnare, S. Ernstgard, l., Sjogren, B, Johanson, g.
- Year:
- 2 007
- Bibliographic source:
- Toxicology Letters, 172, 120-130
Materials and methods
- Type of study / information:
- Nine male volunteers were experimentally exposed to 500 ppm HFC-143a for 2-hr during light exercise (50W) in an exposure chamber. Blood urine and exhaled air were sampled before, during and after exposure and analyzed for HFC-143a by gas chromatography. These data were described by a PBTK model. The electrocardiograms of the volunteers were monitored during exposure. Volunteers rated symptoms related to irritation and CNS-symptoms on a visual analog scale. Inflamatory markers and uric acid were analyzed in plasma collected before and 21 hr after exposure. The exposures were preformed after informed consent and ethical approval.
- Endpoint addressed:
- acute toxicity: inhalation
Test guideline
- Qualifier:
- no guideline available
- Principles of method if other than guideline:
- Nine male volunteers were experimentally exposed to 500 ppm HFC-143a for 2-hr during light exercise (50W) in an exposure chamber. Blood urine and exhaled air were sampled before, during and after exposure and analyzed for HFC-143a by gas chromatography. These data were described by a PBTK model. The electrocardiograms of the volunteers were monitored during exposure. Volunteers rated symptoms related to irritation and CNS-symptoms on a visual analog scale. Inflamatory markers and uric acid were analyzed in plasma collected before and 21 hr after exposure. The exposures were preformed after informed consent and ethical approval.
- GLP compliance:
- not specified
Test material
- Reference substance name:
- 1,1,1-trifluoroethane
- EC Number:
- 206-996-5
- EC Name:
- 1,1,1-trifluoroethane
- Cas Number:
- 420-46-2
- Molecular formula:
- C2H3F3
- IUPAC Name:
- 1,1,1-trifluoroethane
Constituent 1
Method
- Ethical approval:
- confirmed and informed consent free of coercion received
- Details on study design:
- Volunteers were exposed for 2 hr. Blood samples were collected before during (4 times) and after (7 times) exposure. Blood HFC-143a levels were analyzed by gas chromatography. The method error was 3.5%. Partition coefficients were calculated and a PBTK model was constructed. Urine was collected before exposure and 2, 4 and 6 hr after the beginning of the exposure. Urine was analyzed by head space analysis for HFC-143a. Volunteers completed a questionaire that rated their perceived discomfort by answering 10 questions related to irritation and CNS-symptoms.
- Exposure assessment:
- measured
- Details on exposure:
- Nine healthy volunteers participated in the study. All had been occupationally exposed to hydrofluorocarbons. Only persons judged to be healthy by a physician following a complete physical examination were allowed to participate. Volunteers were exposed in a 20 m3 chamber for 2-hr. HFC-143a was introduced into the chamber via a preheated glass tube. Flow was controlled using a calibrated mass flow meter. Exposure levels were 500 ppm and were monitored by gas chromatography. During exposure, volunteers exercised at 50W on a computer-controlled bicycle ergometer.
Results and discussion
- Results:
- The plasma concentration of HFC-143a increased promptly at the start of exposure and decreased in the same mannor post exposure. A stable level of 4.8 +/- 2.0 microM was reached within 30 minutes of exposure. Urinary excretion of HFC-143a was 0.0007% of the inhaled amount. The half time in urine was 53 minutes. The experimental and simulated time courses in blood and exhaled air were in good agreement. The simulated relative uptake during exposure was 1.6 +/- 0.3%. The fibrogen level in plasma had increased by 11% by the next day. While this may be an indicator of irritation, none of the other more sensitive markers for inflamatory responses were elevated nor were levels of uric acid. No effects of exposure were seen either in the electrocardiogram or as symptom ratings. The metabolism is either zero or near zero.
Any other information on results incl. tables
Nine volunteers were exposed to 500 ppm of HFC-143a for 2 hrs under moderate exercise (50W). The experiment is well described by the PBTK model and the uptake is low. An apparent steady-state is reached within minutes. The kinetic behavior is in agreement with a very low blood:air partition coefficient, and zero metabolism. No effects were seen on the electrcardiogram nor were signs of irritation reported on the symptom questionnaire.
Applicant's summary and conclusion
- Conclusions:
- Nine male volunteers were experimentally exposed to 500 ppm HFC-143a for 2-hr during light exercise (50W) in an exposure chamber. Blood urine and exhaled air were sampled before, during and after exposure and analyzed for HFC-143a by gas chromatography. These data were described by a PBTK model. The electrocardiograms of the volunteers were monitored during exposure. Volunteers rated symptoms related to irritation and CNS-symptoms on a visual analog scale. Inflammatory markers and uric acid were analyzed in plasma collected before and 21 hr after exposure. The exposures were preformed after informed consent and ethical approval. The experiment is well described by the PBTK model and the uptake is low. An apparent steady-state is reached within minutes. The kinetic behavior is in agreement with a very low blood:air partition coefficient, and zero metabolism. No effects were seen on the electrcardiogram nor were signs of irritation reported on the symptom questionnaire.The experiment is well described by the PBTK model and the uptake is low. An apparent steady-state is reached within minutes. The kinetic behavior is in agreement with a very low blood:air partition coefficient, and zero metabolism. No effects were seen on the electrcardiogram nor were signs of irritation reported on the symptom questionnaires.
- Executive summary:
Nine male volunteers were experimentally exposed to 500 ppm HFC-143a for 2-hr during light exercise (50W) in an exposure chamber. Blood urine and exhaled air were sampled before, during and after exposure and analyzed for HFC-143a by gas chromatography. These data were described by a PBTK model. The electrocardiograms of the volunteers were monitored during exposure. Volunteers rated symptoms related to irritation and CNS-symptoms on a visual analog scale. Inflammatory markers and uric acid were analyzed in plasma collected before and 21 hr after exposure. The exposures were preformed after informed consent and ethical approval. The experiment is well described by the PBTK model and the uptake is low. An apparent steady-state is reached within minutes. The kinetic behavior is in agreement with a very low blood:air partition coefficient, and zero metabolism. No effects were seen on the electrcardiogram nor were signs of irritation reported on the symptom questionnaire.The experiment is well described by the PBTK model and the uptake is low. An apparent steady-state is reached within minutes. The kinetic behavior is in agreement with a very low blood:air partition coefficient, and zero metabolism. No effects were seen on the electrcardiogram nor were signs of irritation reported on the symptom questionnaires.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
